NCT03976167

Brief Summary

Randomized controled trial to compare oxygen desaturation during fiberoptic bronchoscopy using oxygen administered with nasal prongs and high flow nasal cannula. Drops in oxygen saturation are frequent during bronchoscopy and limit the procedure compromising patient security. The investigator's aim is to contribute to select better way of oxygen administration which could prevent desaturations during bronchoscopy in children.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2015

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
Last Updated

June 10, 2019

Status Verified

June 1, 2019

Enrollment Period

3.3 years

First QC Date

May 30, 2019

Last Update Submit

June 6, 2019

Conditions

Keywords

ChildrenDesaturationsBronchoscopyOxygenHigh flow oxygen

Outcome Measures

Primary Outcomes (1)

  • Oxygen desaturation

    Number of patients with Oxygen saturation under 94% during bronchoscopy

    Trough study completion, an average of 2 years

Secondary Outcomes (5)

  • Moderate oxygen desaturations

    Trough study completion, an average of 2 years

  • Severe oxygen desaturations

    Trough study completion, an average of 2 years

  • Tachypnea

    Trough study completion, an average of 2 years

  • Apnea

    Trough study completion, an average of 2 years

  • Bradycardia

    Trough study completion, an average of 2 years

Study Arms (2)

Common nasal cannula

ACTIVE COMPARATOR

Oxygen administration up to 4 liters according defined protocol

Device: Oxygen administration with Common nasal cannula

High flow nasal cannula

EXPERIMENTAL

Oxygen administered with high flow nasal cannula according child weight and protocol designed for this study

Device: Oxygen administration with high flow nasal cannula, device Airvo2 Fisher and Pykel

Interventions

Oxygen administration during elective flexible bronchoscopy in children with high flow nasal cannula with inspired oxygen fraction 1.

Common nasal cannula

Eligibility Criteria

Age29 Days - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • elective flexible bronchoscopy

You may not qualify if:

  • admitted in Neonatal intensive care
  • previous respiratory support: oxygen any device, non invasive or invasive ventilation
  • patient who may benefit with continuous positive pressure during procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Sharluyan A, Osona B, Frontera G, Brandstrup KB, Figuerola J, Sanz-Ruiz I, Salas A, Garrido B, Eva CG, Fernandez A, Pena-Zarza JA, Gil JA, Bover-Bauza C, Sailer S. High flow nasal cannula versus standard low flow nasal oxygen during flexible bronchoscopy in children: A randomized controlled trial. Pediatr Pulmonol. 2021 Dec;56(12):4001-4010. doi: 10.1002/ppul.25655. Epub 2021 Sep 10.

MeSH Terms

Conditions

Respiration Disorders

Interventions

Oxygen Inhalation Therapy

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Respiratory TherapyTherapeutics

Study Officials

  • Artur sharluyan, MD

    Ib-salut

    PRINCIPAL INVESTIGATOR
  • Sebastian Sailer, MD

    Ib-salud

    STUDY DIRECTOR
  • Francisco de Borja Osona Rodriguez, PhD

    Ib-salud

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2019

First Posted

June 5, 2019

Study Start

November 10, 2015

Primary Completion

February 28, 2019

Study Completion

February 28, 2019

Last Updated

June 10, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share